Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/22441
Title: | Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. |
Author: | Font Franco, Josep, 1953-2006 Cervera i Segura, Ricard, 1960- Espinosa Garriga, Gerard Pallarés Ferreres, Lucio Ramos Casals, Manuel Jiménez, Sònia García Carrasco, Mario Seisdedos, Luis Ingelmo Morín, Miguel |
Keywords: | Lupus eritematós Malalties dels infants Adults Immunologia Lupus erythematosus Children's diseases Adulthood Immunology |
Issue Date: | 1998 |
Publisher: | BMJ Group |
Abstract: | OBJECTIVE—To define the pattern of disease expression in patients with childhood onset systemic lupus erythematosus (SLE). METHODS—Prospective analysis of clinical manifestations and immunological features of 34 patients in whom the first manifestations appeared in childhood from a series of 430 unselected patients with SLE. RESULTS—Thirty one (91%) patients from the childhood onset group were female and three male (9%) (ratio female/male, 10/1, with no difference compared with the adult onset group). Mean age of this group at disease onset was 11 years (range 5-14) compared with 32 years (15-48) for the remaining patients. The childhood onset patients more often had nephropathy (20% v 9% in adult onset SLE, p=0.04; OR:2.7; 95%CI:1.1, 7), fever (41% v 21%, p=0.006; OR:2.6, 95%CI:1.2, 5.7), and lymphadenopathy (6% v 0.5%, p=0.03, OR: 12.3, 95%CI: 1.2, 127.6), as presenting clinical manifestations. During the evolution of the disease, the childhood onset patients had an increased prevalence of malar rash (79% v 51%, p=0.002; OR:3.7; 95%CI:1.5, 9.5) and chorea (9% v 0%, p<0.0001). This group exhibited a higher prevalence of anticardiolipin antibodies (aCL) of the IgG isotype when compared with the remaining patients (29% v 13%, p=0.017; OR:2.9, 95%CI:1.2, 6.8). No significant differences were found among the other antibodies between the two groups. Childhood onset patients more often received azathioprine (15% v 6%, p=0.00004; OR:11.2; 95%CI:2.8, 44.9) but no differences were detected between the groups concerning side effects or drug toxicity. CONCLUSIONS—The presentation and the clinical course of SLE varied in this series of 430 patients depending on their age at disease onset. Nephropathy, fever, and lymphadenopathy were more common in childhood onset patients as presenting clinical manifestations, while malar rash, chorea, and detection of IgG aCL were more common during the evolution of the disease. |
Note: | Reproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.57.8.456 |
It is part of: | Annals of the Rheumatic Diseases, 1998, vol. 57, núm. 8, p. 456-459 |
URI: | http://hdl.handle.net/2445/22441 |
Related resource: | http://dx.doi.org/10.1136/ard.57.8.456 |
ISSN: | 0003-4967 |
Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
565794.pdf | 161.93 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.